MERRIMACK PHARMACEUTICALS IN

CUSIP: 590328209 Class: Common Stock

BRIDGEWAY CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001107261)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 34,200 Value ($000) $505 Avg Close Range
Q4 2023
Shares 34,200 Value ($000) $459 Avg Close Range
Q3 2023
Shares 34,200 Value ($000) $422 Avg Close Range
Q2 2023
Shares 34,200 Value ($000) $421 Avg Close Range
Q1 2023
Shares 34,200 Value ($000) $420 Avg Close Range
Q4 2022
Shares 34,200 Value ($000) $392 Avg Close Range
Q3 2022
Shares 34,200 Value ($000) $128 Avg Close Range
Q2 2022
Shares 59,200 Value ($000) $352 Avg Close Range
Q1 2022
Shares 59,200 Value ($000) $374 Avg Close Range
Q4 2021
Shares 59,200 Value ($000) $231 Avg Close Range
Q3 2021
Shares 59,200 Value ($000) $286 Avg Close Range
Q2 2021
Shares 59,200 Value ($000) $378 Avg Close Range
Q1 2021
Shares 64,200 Value ($000) $403 Avg Close Range
Q4 2020
Shares 61,700 Value ($000) $425 Avg Close Range
Q3 2020
Shares 61,700 Value ($000) $247 Avg Close Range
Q2 2020
Shares 61,700 Value ($000) $205 Avg Close Range
Q1 2020
Shares 61,700 Value ($000) $133 Avg Close Range
Q4 2019
Shares 61,700 Value ($000) $194 Avg Close Range
Q3 2019
Shares 61,700 Value ($000) $277 Avg Close Range
Q2 2019
Shares 61,700 Value ($000) $373 Avg Close Range
Q1 2019
Shares 26,700 Value ($000) $186 Avg Close Range
Q3 2018
Shares 63,200 Value ($000) $337 Avg Close Range
Q2 2018
Shares 63,200 Value ($000) $310 Avg Close Range